Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 2 |
2013 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter.
Nat Struct Mol Biol. 2024 Jan;31(1):159-169. doi: 10.1038/s41594-023-01134-0. Epub 2023 Dec 6.
Nat Struct Mol Biol. 2024.
PMID: 38057552
Free PMC article.
Machine learning to estimate the local quality of protein crystal structures.
Miyaguchi I, Sato M, Kashima A, Nakagawa H, Kokabu Y, Ma B, Matsumoto S, Tokuhisa A, Ohta M, Ikeguchi M.
Miyaguchi I, et al.
Sci Rep. 2021 Dec 8;11(1):23599. doi: 10.1038/s41598-021-02948-y.
Sci Rep. 2021.
PMID: 34880321
Free PMC article.
Item in Clipboard
Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.
Yoshida T, Akahoshi F, Sakashita H, Sonda S, Takeuchi M, Tanaka Y, Nabeno M, Kishida H, Miyaguchi I, Hayashi Y.
Yoshida T, et al. Among authors: miyaguchi i.
Bioorg Med Chem. 2012 Aug 15;20(16):5033-41. doi: 10.1016/j.bmc.2012.06.033. Epub 2012 Jul 5.
Bioorg Med Chem. 2012.
PMID: 22824762
Item in Clipboard
A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.
Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, Kadowaki T.
Nabeno M, et al. Among authors: miyaguchi i.
Biochem Biophys Res Commun. 2013 May 3;434(2):191-6. doi: 10.1016/j.bbrc.2013.03.010. Epub 2013 Mar 15.
Biochem Biophys Res Commun. 2013.
PMID: 23501107
Item in Clipboard
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Yoshida T, Akahoshi F, Sakashita H, Kitajima H, Nakamura M, Sonda S, Takeuchi M, Tanaka Y, Ueda N, Sekiguchi S, Ishige T, Shima K, Nabeno M, Abe Y, Anabuki J, Soejima A, Yoshida K, Takashina Y, Ishii S, Kiuchi S, Fukuda S, Tsutsumiuchi R, Kosaka K, Murozono T, Nakamaru Y, Utsumi H, Masutomi N, Kishida H, Miyaguchi I, Hayashi Y.
Yoshida T, et al. Among authors: miyaguchi i.
Bioorg Med Chem. 2012 Oct 1;20(19):5705-19. doi: 10.1016/j.bmc.2012.08.012. Epub 2012 Aug 17.
Bioorg Med Chem. 2012.
PMID: 22959556
Item in Clipboard
Cite
Cite